Starbucks Drops Limited-Edition Motto Frappuccino in Japan Stores 
Visa's Q2 Earnings Surpass Expectations, Fueled by Consumer Spending 
If plastic manufacturing goes up 10%, plastic pollution goes up 10% – and we’re set for a huge surge in production 
Tesla Reveals Plans to Release New EVs Earlier Than Scheduled, to Introduce Cheaper Models 
LG Energy Solution to Combat Infringement By Launching Licensing Business for Battery Patents 
Tesla Nears FSD Licensing Deal with Major Automaker, Hits 1.3 Billion Milestone 
Family farms are fast disappearing: our research shows how young generations can take them up successfully 
IBM Acquires HashiCorp, Giving Its Hybrid-Cloud Business a Boost 
Mercedes-Benz to Release Luxury Electric Van in China 
Volvo Cars Projects Robust Demand Despite Financial Hiccups in Q1 
Boeing Experiences Quarterly Revenue Drop Amid Production Challenges, Beat Expectations 
Whirlpool’s Stale Demand Led to 1,000 Job Cuts in the US 
Ferrari F1 Announces Multi-Year Partnership with HP as Title Sponsor 
Tesla Model 3 Performance Eligible for $7,500 Tax Credit, Launches at $53K 
Why is the London Stock Exchange losing out to the US 
PUMA x Ottolinger Unveil Futuristic Collection Inspired by Motorsport and Sci-Fi 
TikTok Vows to Fight US Ban After Biden Signed Bill 
EVRY, France, June 27, 2016 -- Global Bioenergies (Alternext Paris: ALGBE) announces having delivered isobutene produced at its industrial pilot to Clariant, a leading specialty chemical company.
Clariant is a Swiss stock-market listed company with revenues exceeding 5 billion euros in 2015, active in a variety of chemical markets such as specialty polymers.
Global Bioenergies' most advanced program consists in the production of high-purity isobutene from renewable resources. A sample of such renewable isobutene, produced at the company's industrial pilot plant, has been shipped to Clariant, where tests regarding Clariant's application of interest have been carried out successfully.
Thomas Buhl, Head of Business Development at Global Bioenergies comments: "After Cristal Union, Audi, Arkema, CFBP, Arlanxeo and L'Oréal, we are pleased to add a seventh company to our list of major industrialists interested in our technology. Clariant is known for developing innovative solutions towards a more environment-friendly chemistry, a mission shared by Global Bioenergies."
About GLOBAL BIOENERGIES
Global Bioenergies is one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation. The Company initially focused its efforts on the production of isobutene, one of the most important petrochemical building blocks that can be converted into fuels, plastics, organic glass and elastomers. Global Bioenergies continues to improve the performances of its process, operates its industrial pilot, builds its demo plant in Germany, and prepares the first full-scale plant through a Joint-Venture with Cristal Union, named
IBN-One. The company also replicated its achievement to propylene and butadiene, two members of the gaseous olefins family, key molecules at the heart of petrochemical industry. Global Bioenergies is listed on Alternext, Euronext Paris (FR0011052257 - ALGBE).
Should you like to be kept informed, subscribe to our news feed on
www.global-bioenergies.com
Follow us on Twitter: @GlobalBioenergi
Contact
GLOBAL BIOENERGIES
Thomas BUHL
Head of Business Development
Phone: +33 (0)1 64 98 20 50
Email: [email protected]
Press release http://hugin.info/166909/R/2023313/751756.pdf
HUG#2023313
